New Drug Combination Shows Promise for Peritoneal Mesothelioma,

The study was part of a multicohort clinical trial at MD Anderson evaluating this drug combination in several rare, solid cancers, including appendiceal …, The study was part of a multicohort clinical trial at MD Anderson evaluating this drug combination in several rare, solid cancers, including appendiceal …, Read More

Scroll to Top